NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
3.270
+0.320 (10.85%)
At close: Oct 23, 2026, 4:00 PM EDT
3.280
+0.010 (0.31%)
After-hours: Oct 23, 2026, 7:30 PM EDT
NTHI Revenue
NeOnc Technologies Holdings had revenue of $39.99K in the twelve months ending June 30, 2026, up 99.95% year-over-year. In the year 2025, NeOnc Technologies Holdings had annual revenue of $39.99K, down -51.82%. That makes NeOnc Technologies Holdings the 46,655th largest company in the world by revenue and 6,993rd in the United States.
Revenue (ttm)
$39.99K
Revenue Growth
+99.95%
P/S Ratio
2,032.55
Revenue / Employee
$7,998
Employees
5
Market Cap
81.28M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 39.99K | -43.01K | -51.82% |
| Dec 31, 2024 | 83.00K | 12.54K | 17.79% |
| Dec 31, 2023 | 70.46K | 50.46K | 252.31% |
| Dec 31, 2022 | 20.00K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cellectis | 63.82M |
| Champions Oncology | 60.66M |
| Spero Therapeutics | 47.00M |
| Pelthos Therapeutics | 43.30M |
| Nutriband | 1.62M |
| MediciNova | 920.48K |
| Cardiff Oncology | 508.00K |
NTHI News
- 1 day ago - NeOnc Breaks Through Key Levels, as Brain-Cancer Stock's Catalysts Continue - GlobeNewsWire
- 2 days ago - NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight - GlobeNewsWire
- 2 days ago - NeOnc Technologies to Be Featured on Health Uncensored with Dr. Drew to Discuss Reaching Brain Tumors Without Surgery or Systemic Chemotherapy - GlobeNewsWire
- 3 days ago - NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches - Newsfile Corp
- 3 days ago - NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward - GlobeNewsWire
- 3 days ago - NeOnc Technologies and the Department of Health – Abu Dhabi Sign MoU to Advance Brain Cancer Research and Proposed Clinical Collaboration - GlobeNewsWire
- 4 days ago - Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season - GlobeNewsWire
- 8 days ago - NeOnc's Most Challenging Test Yet: Compassionate-Use Update Puts NEO100's Potential in Focus - Newsfile Corp